Table 2.
Differentiating features of C3 glomerulopathy and aHUS
C3 glomerulopathy | aHUS | |
---|---|---|
Clinical features | Hematuria, proteinuria, renal failure | Hematuria, proteinuria, renal failure, thrombocytopenia and anemia |
Multi-system involvement | No | Yes |
Laboratory parameters | Proteinuria, hematuria, increased BUN and Cr, low GFR | Proteinuria, hematuria, increased BUN and Cr, low GFR Thrombocytopenia (relative or absolute), anemia, low haptoglobin, elevated LDH, schistocytes on peripheral smear can be observed |
ADAMTS-13 | At present no role in establishing the diagnosis | Important in establishing the diagnosis |
Renal biopsy | Required to make the diagnosis | Not required to make the diagnosis |
Pathophysiology | Alternate complement pathway dysregulation (fluid phase) | Alternate complement pathway dysregulation (solid phase) |
Prognosis | Relatively better prognosis | Worse prognosis with high recurrence |
Treatment | Role of complement pathway blockade is controversial | Role of complement blockade established |
aHUS, atypical hemolytic uremic syndrome; BUN, blood urea nitrogen; Cr, creatinine; GFR, glomerular filtration rate; LDH, lactate dehydrogenase.